HOOKIPA Pharma Inc (HOOK)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-08-22 | 2023-08-21 | B Purchase |
Chief Financial Officer Executive Director |
7,000
+19.4%
0.73USD 5,075 |
7,000 +19.4% | 0.73 | USD 5,075 | |
| 2023-08-17 | 2023-08-16 | B Purchase |
Chief Financial Officer Executive Director |
8,000
+28.5%
0.71USD 5,712 |
8,000 +28.5% | 0.71 | USD 5,712 | |
| 2023-07-11 | 2023-07-11 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+7.5%
0.83USD 4,142 |
5,000 +7.5% | 0.83 | USD 4,142 | |
| 2023-07-11 | 2023-07-07 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+8.1%
0.81USD 4,050 |
5,000 +8.1% | 0.81 | USD 4,050 | |
| 2023-07-07 | 2023-07-05 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+8.8%
0.89USD 4,450 |
5,000 +8.8% | 0.89 | USD 4,450 | |
| 2023-07-05 | 2023-07-03 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+9.6%
0.89USD 4,456 |
5,000 +9.6% | 0.89 | USD 4,456 | |
| 2023-07-03 | 2023-06-30 | B Purchase |
Chief Financial Officer Executive Director |
12,000
+74.6%
0.88USD 10,560 |
12,000 +74.6% | 0.88 | USD 10,560 | |
| 2022-01-12 | 2021-12-21 | S Sale |
Chief Medical Officer Officer |
2,205
-2.5%
2.49USD 5,490 |
2,205 -2.5% | 2.49 | USD 5,490 | |
| 2022-01-12 | 2021-12-21 | S Sale |
Chief Medical Officer Officer |
7,440
-8.1%
2.49USD 18,526 |
7,440 -8.1% | 2.49 | USD 18,526 | |
| 2022-01-12 | 2021-12-21 | S Sale |
Chief Medical Officer Officer |
5,304
-6.2%
2.49USD 13,207 |
5,304 -6.2% | 2.49 | USD 13,207 | |
| 2021-04-23 | 2021-04-21 | S Sale | Large shareholder |
328,620
-9.4%
11.60USD 3,812,386 |
328,620 -9.4% | 11.60 | USD 3,812,386 | |
| 2021-03-29 | 2021-03-25 | PS Planned sale | Large shareholder |
28,546
-0.8%
13.12USD 374,569 |
28,546 -0.8% | 13.12 | USD 374,569 | |
| 2021-03-26 | 2021-03-24 | PS Planned sale | Large shareholder |
52,690
-1.4%
13.70USD 721,616 |
52,690 -1.4% | 13.70 | USD 721,616 | |
| 2021-03-25 | 2021-03-23 | PS Planned sale | Large shareholder |
40,000
-1.1%
13.91USD 556,476 |
40,000 -1.1% | 13.91 | USD 556,476 | |
| 2021-03-24 | 2021-03-22 | PS Planned sale | Large shareholder |
40,534
-1.1%
14.54USD 589,263 |
40,534 -1.1% | 14.54 | USD 589,263 | |
| 2021-03-23 | 2021-03-19 | PS Planned sale | Large shareholder |
166,230
-4.3%
14.60USD 2,427,739 |
166,230 -4.3% | 14.60 | USD 2,427,739 | |
| 2020-12-18 | 2020-12-17 | S Sale |
Chief Medical Officer Officer |
16,478
-17.6%
11.76USD 193,781 |
16,478 -17.6% | 11.76 | USD 193,781 | |
| 2020-12-18 | 2020-12-17 | S Sale |
Chief Medical Officer Officer |
11,501
-15.2%
11.70USD 134,562 |
11,501 -15.2% | 11.70 | USD 134,562 | |
| 2020-12-18 | 2020-12-16 | S Sale |
Chief Medical Officer Officer |
380
-0.7%
11.70USD 4,446 |
380 -0.7% | 11.70 | USD 4,446 | |
| 2020-10-06 | 2020-10-02 | PS Planned sale | Large shareholder |
300
-0.0%
10.00USD 3,000 |
300 -0.0% | 10.00 | USD 3,000 | |
| 2020-09-17 | 2020-09-15 | PS Planned sale | Large shareholder |
9,261
-0.2%
13.16USD 121,913 |
9,261 -0.2% | 13.16 | USD 121,913 | |
| 2020-09-17 | 2020-09-15 | PS Planned sale | Large shareholder |
32,336
-0.8%
12.45USD 402,564 |
32,336 -0.8% | 12.45 | USD 402,564 | |
| 2020-07-22 | 2020-07-20 | PS Planned sale | Large shareholder |
12,483
-0.3%
11.94USD 149,102 |
12,483 -0.3% | 11.94 | USD 149,102 | |
| 2020-07-22 | 2020-06-29 | PS Planned sale | Large shareholder |
3,280
-0.1%
11.78USD 38,628 |
3,280 -0.1% | 11.78 | USD 38,628 | |
| 2020-07-01 | 2020-06-29 | PS Planned sale | Large shareholder |
3,280
-0.1%
11.78USD 38,628 |
3,280 -0.1% | 11.78 | USD 38,628 | |
| 2020-01-31 | 2020-01-29 | S Sale |
Chief Medical Officer |
5,500
-9.3%
12.73USD 69,992 |
5,500 -9.3% | 12.73 | USD 69,992 | |
| 2020-01-27 | 2020-01-23 | S Sale |
Sr. VP, Technical Development |
7,568
-100.0%
12.81USD 96,932 |
7,568 -100.0% | 12.81 | USD 96,932 | |
| 2020-01-27 | 2020-01-23 | S Sale |
Sr. VP, Technical Development |
4,075
-100.0%
12.17USD 49,601 |
4,075 -100.0% | 12.17 | USD 49,601 | |
| 2020-01-21 | 2020-01-21 | S Sale |
Sr. VP, Research |
6,789
-100.0%
12.02USD 81,592 |
6,789 -100.0% | 12.02 | USD 81,592 | |
| 2020-01-21 | 2020-01-16 | S Sale |
Sr. VP, Research |
1,711
-100.0%
11.56USD 19,781 |
1,711 -100.0% | 11.56 | USD 19,781 | |
| 2020-01-16 | 2020-01-14 | S Sale |
Sr. VP, Research |
8,500
-100.0%
11.30USD 96,053 |
8,500 -100.0% | 11.30 | USD 96,053 | |
| 2019-12-23 | 2019-12-19 | S Sale |
Matushansky Igor Chief Medical Officer Officer |
10,404
-15.0%
9.93USD 103,312 |
10,404 -15.0% | 9.93 | USD 103,312 | |
| 2019-12-19 | 2019-12-17 | S Sale |
Matushansky Igor Chief Medical Officer Officer |
11,484
-20.9%
7.87USD 90,379 |
11,484 -20.9% | 7.87 | USD 90,379 | |
| 2019-04-25 | 2019-04-23 | B Purchase |
Forbion Capital Fund II Cooperatief U.A. Large shareholder |
53,571
+2.2%
14.00USD 749,994 |
53,571 +2.2% | 14.00 | USD 749,994 | |
| 2019-04-25 | 2019-04-23 | B Purchase | Large shareholder |
357,142
+9.9%
14.00USD 4,999,988 |
357,142 +9.9% | 14.00 | USD 4,999,988 | |
| 2019-04-23 | 2019-04-23 | B Purchase |
Former 10% owner |
820,729
+inf%
14.00USD 11,490,206 |
820,729 +inf% | 14.00 | USD 11,490,206 | |
| 2019-04-23 | 2019-04-23 | B Purchase |
Former 10% owner |
72,128
+inf%
14.00USD 1,009,792 |
72,128 +inf% | 14.00 | USD 1,009,792 |